SONO TEK CORP
Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.
Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.
SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati
Over the past 7 days, alphai's AI scored 1 news story mentioning SOTK (SONO TEK CORP). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent SOTK coverage spans financial news and earnings.
In the last 30 days, SOTK insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($159K). The most active reporter was Bagley Stephen James, CFO, with 3 filings.
The disclosed record production-line purchase order is a near-term revenue visibility positive and supports scaling demand for Sono-Tek’s medical device coating systems.
Results show improving profitability and a medical-led mix shift, with full-year revenue still guided flat to modestly higher.
Quarterly profitability improved alongside margin expansion, with medical demand cited as the primary growth driver.
Guidance and backlog mix shift toward medical/microelectronics with longer lead times raise near-term volatility risk but support margin/operating leverage.
Strong FY2026 profitability expansion plus 1H FY2027 revenue growth expectations should support near-term sentiment, while clean-energy order uncertainty caps visibility beyond 1H.
alphai scores every news story that mentions SOTK with an AI model for sentiment and relevance, and aggregates insider trades from SONO TEK CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.
2 min readSono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.
4 min readSONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati
6 min readSono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.
6 min readSono-Tek (Nasdaq: SOTK) reported FY2026 net sales of $20.9M (+2% YoY), gross margin of 51% (up from 47.5%), operating income of $1.82M (+81%), and net income of about $1.8M (+42%), according to the company. Q4 net sales were $5.6M (+10%). Backlog was $9.1M. The company expects continued 1H FY2027 revenue growth driven by medical and high-ASP systems; FY2027 revenue projected flat to modestly higher.
6 min readSono-Tek Corporation (NASDAQ: SOTK) has announced its conference call to discuss fiscal fourth quarter and full year 2026 financial results, which ended on February 28, 2026. The call is scheduled for Thursday, May 28, 2026, at 10:30 am ET, with the financial results press release issued before market open on the same day. Dial-in and webcast information for the call and replays are provided, along with company information highlighting Sono-Tek's leadership in ultrasonic coating systems.
3 min readSono-Tek Corp., a microcap industrial manufacturing company, has undergone a stock valuation adjustment, showing a high P/E ratio of 42 compared to its peers. Despite a strong ROCE of 17.11% and ROE of 8.16%, its stock return of 5.76% over the past year significantly underperformed the S&P 500's 17.45%, highlighting competitive pressures. The article details the company's financial metrics against competitors and discusses its relative market performance.
4 min readVSTM, AS and SOTK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 21, 2025.
2 min readSonoTek (SOTK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 min readImage source: The Motley Fool.Tuesday, October 14, 2025 at 10:30 a.m. ETExecutive Chairman - Dr. Chris CoccioContinue reading ...
4 min read
